AFAbdel-Motaal Fouda

Abdel-Motaal Fouda

*This is an algorithmically generated author record based on publicly available information.

Abdel-Motaal Fouda has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Same Substitutions, Opposite Residence Times: Target-Dependent Kinetic Inversion of Diazabicyclooctane 𝛽-Lactamase Inhibitors

    by Abdel-Motaal M. Fouda, Dina A. Fouda

    Reversible covalent inhibitors are governed by both formation and breakdown of the covalent complex, yet matched medicinal-chemistry modifications are often interpreted through affinity or potency alone. We performed an original quantitative reanalysis of published experimental kinetics and corresponding covalent crystal structures for four diazabicyclooctane (DBO) inhibitors—avibactam, FPI-1465, FPI-1523, and FPI-1602—against CTX-M-15 and OXA-48. Relative to avibactam, all three C2-modified analogues showed lower 𝑘2/𝐾𝑖 in both enzymes, but their effects on dissociation reversed sign between targets. FPI-1465, FPI-1523, and FPI-1602 dissociated 3.86-, 3.38-, and 4.91-fold more slowly from CTX-M-15, whereas they dissociated 68.8-, 3.12-, and 2.73-fold more rapidly from OXA-48. The corresponding cross-target interactions were 265.5-, 10.5-, and 13.4-fold. Eyring transformation mapped these effects to shifts in the reverse activation barrier of +0.72 to +0.94 kcal mol−1 in CTX-M-15 versus −0.59 to −2.51 kcal mol−1 in OXA-48. Static oxyanion-hole geometry did not encode the OXA-48 ranking: mean donor–carbonyl-oxygen distances changed by only 0.002–0.065 Å relative to avibactam despite 2.7–68.8-fold changes in 𝑘off. These findings identify a replicated target-dependent residence-time inversion and demonstrate that forward and reverse structure–kinetic relationships can diverge within a matched reversible-covalent series. Conformational ensembles and distributed electrostatics emerge as specific prospective mechanisms, but are not inferred as causal from the present static-structure analysis.

  • Open Access

    Identifiability Boundaries in Dynamic GPCR Pharmacology: When Desensitization, Internalization and Persistent Signaling Become Mechanistically Indistinguishable

    by Abdel-Motaal M. Fouda, Dina A. Fouda

    Dynamic GPCR pharmacology increasingly relies on time-resolved signaling to infer receptor regulation, trafficking, and ligand residence, yet a kinetic response need not uniquely identify the mechanism that produced it. We developed minimal quantitative receptor-pharmacology models to determine when desensitization, internalization, persistent intracellular signaling, and slow receptor occupancy are distinguishable from a common downstream signal. We first derived exact input–output equivalences. Silent internalization is mathematically identical to desensitization for arbitrary time-varying receptor drive, whereas internalization with persistent signaling is exactly equivalent to a desensitization model under any single constant drive after an explicit parameter transformation. Across a 1,000system parameter ensemble, pulse–wash protocols broke the constant-drive equivalence but remained practically ambiguous after adversarial refitting: in 500 held-out systems, the wrong desensitization model had a median normalized error of 1.26% when downstream signal decay (kD) was unconstrained. Independent calibration of kD increased this to 11.90% and increased the fraction exceeding a 5% discrepancy from 11.4% to 80.0%. At 5% Gaussian observation noise, correct-model selection by BIC increased from 48.8% to 95.8%. An analytical kinetic blind manifold, kD = kr + qki, predicted where downstream-only discrimination failed. A single surface-receptor observation supplied substantially greater mechanism-specific information, with 95.5% of systems showing >20% surface loss after 5 min. Slow receptor occupancy also mimicked persistent intracellular signaling, but false trafficking fits made strongly divergent surface-state predictions. Published β2-adrenoceptor, AM2 receptor, and VIPR1 experiments provide independent pharmacological examples of the predicted information constraints and discriminating measurements. The resulting quantitative framework shows that mechanistic discrimination may depend more on independently constraining a downstream nuisance process or hidden receptor state than on collecting additional samples of the same downstream response.

  • Open Access

    From Potency Ratios to Target Engagement: Translational Identifiability of Multi-Incretin Receptor Balance

    by Abdel-Motaal Fouda, Dina A. Fouda

    Background and Purpose. Dual and triple incretin agonists are commonly characterized by receptor-potency ratios measured in recombinant systems. For long-acting acylated peptides, however, protein binding, clinical exposure and tissue accessibility may alter the receptor profile expressed in vivo. We examined when in-vitro receptor balance can legitimately be translated into clinical target engagement. Experimental Approach. We developed a four-level framework separating intrinsic receptor pharmacology (M0), protein/plasma-context pharmacology (M1), exposure-weighted functional coverage (M2) and direct tissue target engagement (M3). Analytical expressions were derived for receptor-specific context reweighting, rank robustness and exposure-dependent compression. Published pharmacological, pharmacokinetic and receptor-occupancy data were analysed for contemporary multi-incretin agonists, with uncertainty propagated by Monte Carlo simulation. Key Results. Protein context produced markedly different receptor-specific effects: point-estimate differential context factors were 1.05 for NN1177, 3.12 for tirzepatide and 5.27 for survodutide. Survodutide shifted from approximately 1.6:1 to 8.3:1 GLP-1R:GCGR potency in 100% human plasma, yet clinical exposure predicted high mean functional coverage of both receptors (98.1% and 86.6%). Increasing common exposure analytically compressed, but could not reverse, fixed receptor-potency ordering. Retatrutide showed a highly robust intrinsic GIPR>GLP-1R>GCGR hierarchy, while its quantitative human activation vector remained underidentified. Human SAR425899 PET provided direct evidence of divergence between plasma-level inference and tissue receptor engagement. Conclusion and Implications. Multi-incretin receptor balance is not an invariant molecular property. Separating context-dependent reweighting, exposure-dependent compression and tissue target engagement provides a quantitative basis for determining when receptor-balance claims are pharmacologically identifiable.

  • Open Access

    Vector-Guided Drug Action via Active-Site Electric Fields: A Theoretical Framework Combining Quantum-Mechanical/Molecular-Mechanical Modeling and Vibrational Stark Tuning Principles

    by Abdel-Motaal M. Fouda, Dina A. Fouda

    Traditional rational drug design paradigms rely primarily on spatial complementary interactionssteric fit, localized hydrogen-bonding topologies, and static lipophilicity profiles—within macromolecular binding pockets. These models largely omit the catalytic and kinetic contributions of the large-scale, oriented endogenous electrostatic fields generated within structured enzymatic and receptor microenvironments. Building on experimentally established vibrational Stark effect (VSE) spectroscopy of enzyme active sites, we present a theoretical framework for Vector-Guided Pharmacology, in which the directional alignment between a pharmacophore’s transition dipole moment (∆µ ‡) or ground-state dipole (µ g) and the intrinsic active-site electric field vector (Epocket) is proposed as a determinant of binding affinity and the activation free-energy barrier (∆G‡) for covalent and non-covalent ligand stabilization. We formulate an electrostatic-embedding QM/MM Hamiltonian, consistent with polarizablemultipole (AMOEBA-type) force-field architectures, and derive the linear and quadratic Stark perturbation terms that couple a ligand’s dipole and polarizability to Epocket. Using representative, literature-consistent parameter values (field magnitudes of 10–50 MV/cm, as established by VSE spectroscopy, and transition dipole differences of several debye, typical of polarizable electrophilic warheads), we present illustrative worked evaluations of the model showing that parallel vector alignment can, in principle, lower the activation free energy by several kcal/mol relative to the antialigned configuration. These worked examples are direct, reproducible evaluations of the derived equations for assumed input parameters; they are not the output of new density-functional-theory (DFT) or molecular-dynamics (MD) calculations performed for this study, and no such calculations are claimed. The framework is offered as a conceptual and mathematical foundation, together with a proposed computational validation protocol, for treating electrostatic vector alignment as an orthogonal, testable parameter in rational drug design.

    • 1 November 2019
      • Vol. 70  (6) , 277-289

    Assessment of the Effect of Extract Formulation of Date Palm Kernel on Facial Skin Wrinkles: Biophysical Measurements and Digital Profilometry

    by Aziz Alsohaimi, Abdel-Motaal Fouda

    Previous studies have shown that the date palm kernel contains plenty of phytochemicals of potential rejuvenation benefits to skin. The aim of this study was to investigate a cream form containing date palm kernel extract (DPKE) on facial wrinkle reduction and objective skin parameters in healthy subjects. A cream form containing 5% DPKE was prepared and applied twice daily for 8 weeks on the facial skin of 43 volunteers. Biophysical measurements including skin hydration, elasticity, and pigmentation as well as optical scanning of skin surface were carried out after 4 and 8 weeks. Significant improvement in facial skin hydration, elasticity, and melanin concentration together with reduction in the wrinkle size and depth were observed at the two time points of measurements. In addition, DPKE cream was extremely well tolerated by the facial skin of study participants. The work herein demonstrates and validates the use of cream form containing 5% DPKE over placebo against fine lines and wrinkles, skin pigmentations, skin hydration, and elasticity. This effect may be attributed to synergism of major phytochemicals and phytosterols present in DPKE.

  • Open Access

    Reduction of mitomycin C resistance in human bladder cancer T24 cells by knocking-down ras oncogene

    by Osama Sharaf Eldin, Abdel-Motaal Fouda, Amany R. Youssef, Peter Hamilton, Perry Maxwell, Kate E. Williamson

    Cancer Drug Resistance is journal focuses on pharmacological aspects of drug resistance and its reversal, including molecular mechanisms of drug resistance and drug classes.


  • Open Access

    Curcumin Enhances Chemosensitivity and Apoptosis in T24 Bladder Cancer Cells through Inhibition of the Ras/ MAPK Signaling Pathway

    by Amany R. Youssef, Abdel-Motaal Fouda, Osama Sharaf Eldin

    Background. Curcumin (CUR), a natural phenolic compound, has been recently reported to exert antitumor actions in variety of cancers; however, the exact mechanism(s) is not clear. In this study we investigated whether CUR could inhibit Ras/MAPK pathway and enhance mitomycin C (MMC) cytotoxicity in T24 bladder cancer cells. Methods. T24 cells were cultured with different concentrations of CUR (5, 10, 20 μM) alone or combined with 10 μg/ml MMC. At the end of 72 h culture, cell viability was assessed by MTT assay; apoptosis by flow cytometry; total Ras and ERK1/2 by immunohistochemistry and western blotting. Results. In comparison to cells exposed to MMC alone, cells treated with combined MMC and either 10 or 20 μM CUR showed reduced cell proliferation, disrupted morphological appearance, and increased subG0/G1 apoptotic events. This inhibition was associated with marked reduction of Ras and ERK1/2 expression. Likewise, cells treated with 10 or 20 μM CUR alone showed significant inhibition, while the effect of 5 μM was less obvious. Conclusion. Resistance of T24 cells to cytotoxic effect of MMC is dependent, at least partially, on Ras/ERK activation. CUR at concentrations of 10 and 20 μM in combination with low dose MMC induced toxic synergism in T24 cells. Clinical translation of this experimental study may be reasonable in light of wide safety margin and availability of CUR.


  • Open Access

    Reduction of Hepato-Metabolic Changes in Rat Model of Metabolic Syndrome by Metformin and Atorvastatin Combination

    by Mervat Samy, Abdel-Motaal Fouda, Mohamed-Hesham Daba, Abdel-Rahman Yassin

    Metabolic syndrome (MetS) and the commonly associated nonalcoholic fatty liver disease (NAFLD) is an increasing health concern and hot topic in medical research. Together with lifestyle modification, metformin (MET) and statins are among drugs with potential therapeutic beneft. The aim of this study is to investigate the potential of synergistic combination of MET and atorvastatin (ATR) in rat model of MetS. Methods. Rats were fed on high-carbohydrate, highfat (HCHF) diet for 16 weeks and either of MET, ATR, or their combination were administered from the beginning of the 9th week to the end of the study. Body weight, insulin resistance, plasma lipids, serum transaminases, TNF-α, leptin and adiponectin as well as liver histopathology were assessed. Results. Both MET and ATR worked synergistically to reverse the biochemical and histological abnormalities of MetS and ameliorated steatohepatitis more than their individual effects. Conclusion. The present study clearly demonstrates a synergistic effect of MET an ATR combination to reverse hepato-metabolic abnormalities of MetS/NAFLD in rat model and calls for pursuing subsequent clinical studies to consolidate data at hand


  • Open Access

    Differential Effects of Low-Dose Erythropoietin in Rat Model of Diabetic Nephropathy

    by Abdel-Motaal Fouda, Rehab H. Ashour, Farida El-Banna, Mohamed A. Saad, Fatma A. Mostafa, Manal I. Fouda

    Background. Previous reports on the renoprotective effect of erythropoietin (EPO) in the setting of chronic kidney disease (CKD) have yielded conflicting results. The aim of this study is to clarify the effect of low, non-hematopoietic dose of EPO on the evolution of diabetic nephropathy (DN) in rat model. Methods. Low dose of recombinant human EPO (150 U/kg, s.c. three times/week) was given to streptozotocin (STZ)-induced diabetic rats in two schedules; in the first one, EPO was given from day 2 after STZ injection till the end of the study (28 weeks) as prophylactic treatment; and in the other schedule EPO was given after development of DN (last 8 weeks) as therapeutic treatment. Albuminuria, blood pressure, creatinine clearance, renal venous oxygen tension (vPO2), plasma EPO, hematocrit and renal histopathology were assessed. Results. Unexpectedly, 28 weeks administration of EPO to diabetic rats led to aggravation of albuminuria and worsening of histopathological damage in spite of partial correction of renal hypoxia. Contrary to this, terminal 8 weeks EPO therapy of DN reduced albuminuria and demonstrated some favorable effects on biochemical changes and histologic picture. Conclusion. Low dose EPO exerted differential effects in rat model of DN according to treatment duration. In addition, findings of the present study warrants further investigations of the exact renoprotective role of EPO in diabetic patients with CKD who receive EPO therapy for long periods.


  • Open Access

    Design and Validation of New Data Acquisition System for Isolated Muscle Experiments: Application to Pharmacology Teaching and Research

    by Abdel-Motaal Fouda, Mohamed H. Qutb, Gamal M. Dahab

    In this paper we describe a new data acquisition (DAQ) system for pharmacology experiments involving isolated muscle contraction. The system is composed of hardware acquisition unit and computer software for analysis of signals representing muscle contractions. As compared to mechanoelectrical DAQ systems of other constructions, the advantages of the new system include a high sensitivity (in the order of 1 µN), a wide range of forces recorded (1 µN to 100 mN), linearity throughout the whole range, easy assembly, low costs, long-term calibration stability, good dynamic characteristics and full control graphical interface. The device can be readily adjusted to actual experimental conditions and a variety of muscle preparations. Experimental validation of our DAQ inside the Clinical Pharmacology Department at Mansoura University Faculty of Medicine showed that it can record contractions of isolated muscle preparations with good precision and accuracy. Accordingly, the DAQ system design presented herein with its dedicated software is largely suitable for isolated muscle experiments in both teaching and research in biomedical fields.